Lupus Nephritis Global Clinical Trials Review, H1, 2013
Summary
GlobalData's clinical trial report, "Lupus Nephritis Global Clinical Trials Review, H1, 2013" provides data on the Lupus Nephritis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Lupus Nephritis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Lupus Nephritis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
Understand the dynamics of a particular indication in a condensed manner
Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
Obtain discontinued trial listing for trials across the globe
Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
TOC
Table of Contents
Table of Contents 2
List of Tables 6
List of Figures 8
Introduction 10
Lupus Nephritis 10
Report Guidance 10
Clinical Trials by Region 11
Clinical Trials by Country 12
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 14
Top Five Countries Contributing to Clinical Trials in Europe 15
Top Countries Contributing to Clinical Trials in North America 16
Top Countries Contributing to Clinical Trials in Middle East and Africa 17
Top Five Countries Contributing to Clinical Trials in Central and South America 18
Clinical Trials by BRIC Nations 19
Clinical Trials by G7 Nations 20
Clinical Trials in G7 Nations by Trial Status 21
Clinical Trials by E7 Nations 22
Clinical Trials in E7 Nations by Trial Status 23
Clinical Trials by Phase 24
In Progress Trials by Phase 25
Clinical Trials by Trial Status 26
Unaccomplished Trials of Lupus Nephritis 27
Subjects Recruited Over a Period of Time 30
Prominent Sponsors 31
Top Companies Participating in Lupus Nephritis Therapeutics Clinical Trials 33
Prominent Drug Comparison 35
Clinical Trial Profiles 36
Clinical Trial Overview of Top Companies 36
Astellas Pharma Inc. 36
Clinical Trial Overview of Astellas Pharma Inc. 36
Novartis AG 37
Clinical Trial Overview of Novartis AG 37
Genentech, Inc. 38
Clinical Trial Overview of Genentech, Inc. 38
Merck KGaA 39
Clinical Trial Overview of Merck KGaA 39
Anthera Pharmaceuticals, Inc. 40
Clinical Trial Overview of Anthera Pharmaceuticals, Inc. 40
La Jolla Pharmaceutical Company 41
Clinical Trial Overview of La Jolla Pharmaceutical Company 41
F. Hoffmann-La Roche Ltd. 42
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 42
Janssen Research & Development, LLC 43
Clinical Trial Overview of Janssen Research & Development, LLC 43
Bristol-Myers Squibb Company 44
Clinical Trial Overview of Bristol-Myers Squibb Company 44
Cytomed 45
Clinical Trial Overview of Cytomed 45
SuppreMol GmbH 46
Clinical Trial Overview of SuppreMol GmbH 46
Baxter International Inc. 47
Clinical Trial Overview of Baxter International Inc. 47
Teva Pharmaceutical Industries Limited 48
Clinical Trial Overview of Teva Pharmaceutical Industries Limited 48
Nippon Kayaku Co., Ltd. 49
Clinical Trial Overview of Nippon Kayaku Co., Ltd. 49
Human Genome Sciences, Inc. 50
Clinical Trial Overview of Human Genome Sciences, Inc. 50
Biogen Idec Inc. 51
Clinical Trial Overview of Biogen Idec Inc. 51
Clinical Trial Overview of Top Universities / Institutes / Hospitals 52
Nanjing University 52
Clinical Trial Overview of Nanjing University 52
Chinese University of Hong Kong 53
Clinical Trial Overview of Chinese University of Hong Kong 53
Sun Yat-sen University 54
Clinical Trial Overview of Sun Yat-sen University 54
Faculty of Pharmaceutical Sciences, Chulalongkorn University 55
Clinical Trial Overview of Faculty of Pharmaceutical Sciences, Chulalongkorn University 55
Zhejiang University 56
Clinical Trial Overview of Zhejiang University 56
Tuen Mun Hospital 57
Clinical Trial Overview of Tuen Mun Hospital 57
University of Calgary 58
Clinical Trial Overview of University of Calgary 58
University Medical Center Groningen 59
Clinical Trial Overview of University Medical Center Groningen 59
Saitama Medical University 60
Clinical Trial Overview of Saitama Medical University 60
Ramathibodi Hospital 61
Clinical Trial Overview of Ramathibodi Hospital 61
Universite Catholique de Louvain 62
Clinical Trial Overview of Universite Catholique de Louvain 62
Peking University 63
Clinical Trial Overview of Peking University 63
The Rogosin Institute 64
Clinical Trial Overview of The Rogosin Institute 64
Katholieke Universiteit Leuven 65
Clinical Trial Overview of Katholieke Universiteit Leuven 65
Medical University of Vienna 66
Clinical Trial Overview of Medical University of Vienna 66
The University of Hong Kong 67
Clinical Trial Overview of The University of Hong Kong 67
Shanghai Jiao Tong University 68
Clinical Trial Overview of Shanghai Jiao Tong University 68
Hospital Authority 69
Clinical Trial Overview of Hospital Authority 69
Assistance Publique Hopitaux De Marseille 70
Clinical Trial Overview of Assistance Publique Hopitaux De Marseille 70
Seoul National University Hospital 71
Clinical Trial Overview of Seoul National University Hospital 71
Lupus Nephritis Global Clinical Trials Review, H1, 2013 published by GlobalData in February 15, 2013. This report consists of Pages: 108 and the price starts from US $ 2500.
The contents of this page may be different from the latest version. Please contact us for details.
